The deteriorating economy, unfavorable currency exchange rate, wholesalers cutting back inventory and U.S. patients foregoing care to save money all contributed to a 4 percent slide in first-quarter earnings at Amgen Inc., company officials said in an earnings call Thursday. (BioWorld Today) Read More
